Which ETFs own GMAB?
Genmab A/S · Healthcare · Biotechnology · DK — 30 ETFs hold it, worth $278.1M across 7.99M shares.
Holdings as of Aug 27, 2026 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | NIFE Direxion Fallen Knives ETF | 5.16% | 3.57K | $118.9K | $2.3M | Financials | -2.55% | |
| 2 | EUMV iShares Edge MSCI Min Vol Europe ETF | 3.99% | 448 | $294.5K | $31.7M | Developed Markets | -0.07% | |
| 3 | FBT First Trust NYSE Arca Biotechnology… | 3.61% | 3.12M | $107.3M | $2.97B | Biotech | +0.97% | |
| 4 | CNCR Loncar Cancer Immunotherapy ETF | 3.42% | 35.79K | $917.8K | $12.7M | Biotech | +1.58% | |
| 5 | CANC Tema Oncology ETF | 2.82% | 181.86K | $6.1M | $218.5M | Biotech | +0.28% | |
| 6 | BAD B.A.D. ETF | 1.51% | 2.87K | $0.00 | $9.5M | — | 0.00% | |
| 7 | IBB iShares Biotechnology ETF | 1.23% | 3.90M | $133.9M | $10.84B | Biotech | +0.07% | |
| 8 | HELX Franklin Genomic Advancements ETF | 0.54% | 5.12K | $171.1K | $32.6M | Healthcare | +0.44% | |
| 9 | BUYZ Franklin Disruptive Commerce ETF | 0.53% | 861 | $28.8K | $5.6M | Developed Markets | -0.32% | |
| 10 | FLQH Franklin LibertyQ International Equity… | 0.48% | 186 | $117.5K | $20.4M | Developed Markets | +0.60% | |
| 11 | WDNA WisdomTree BioRevolution Fund | 0.48% | 408 | $11.0K | $3.1M | Healthcare | +0.08% | |
| 12 | HFXE IQ 50 Percent Hedged FTSE Europe ETF | 0.43% | 58 | $32.2K | $8.3M | Developed Markets | +0.54% | |
| 13 | RBIN Nationwide Risk-Based International… | 0.36% | 1.07K | $1.6M | $116.0M | Developed Markets | 0.00% | |
| 14 | VMAT V-Shares MSCI World ESG Materiality and… | 0.27% | 22 | $0.00 | — | — | +0.46% | |
| 15 | FTQI First Trust Nasdaq BuyWrite Income ETF | 0.23% | 65.39K | $2.2M | $948.1M | Covered Call | +0.11% | |
| 16 | PQIN PGIM Quant Solutions Strategic Alpha… | 0.20% | 205 | $274.3K | $33.3M | Developed Markets | +0.34% | |
| 17 | PXUS Principal International Adaptive… | 0.16% | 49 | $17.3K | $14.9M | Developed Markets | +0.57% | |
| 18 | IBBQ Invesco Nasdaq Biotechnology ETF | 0.16% | 4.45K | $148.7K | $95.8M | Biotech | -0.08% | |
| 19 | DMRI DeltaShares S&P International Managed… | 0.15% | 683 | $473.0K | $9.5M | Treasury Bonds | -0.98% | |
| 20 | JHMD John Hancock Investments - Multifactor… | 0.15% | 5.05K | $1.4M | $971.6M | Developed Markets | -0.56% | |
| 21 | AVDE Avantis International Equity ETF | 0.10% | 546.78K | $18.8M | $19.12B | Developed Markets | -0.13% | |
| 22 | APIE ActivePassive International Equity ETF | 0.10% | 32.91K | $1.1M | $953.8M | Developed Markets | +0.07% | |
| 23 | FLQG Franklin U.S. Equity Index ETF | 0.09% | 34 | $14.9K | $422.9M | Developed Markets | +0.81% | |
| 24 | BIB ProShares Ultra Nasdaq Biotechnology | 0.08% | 2.59K | $86.7K | $107.7M | Biotech | -0.06% | |
| 25 | NTSI WisdomTree International Efficient Core… | 0.08% | 1.55K | $409.3K | $501.9M | Developed Markets | -0.18% | |
| 26 | AVSD Avantis Responsible International… | 0.06% | 6.53K | $218.2K | $363.1M | Developed Markets | -0.26% | |
| 27 | AVIV Avantis International Large Cap Value… | 0.03% | 17.48K | $600.7K | $2.09B | Developed Markets | -0.39% | |
| 28 | ONEQ Fidelity Nasdaq Composite Index ETF | 0.01% | 26.14K | $898.2K | $10.35B | — | +1.45% | |
| 29 | DFAI Dimensional - International Core Equity… | 0.00% | 15.28K | $525.0K | $18.36B | Developed Markets | -0.22% | |
| 30 | DFIV Dimensional - International Value ETF | 0.00% | 9.78K | $336.0K | $22.13B | Developed Markets | -0.44% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.